MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 inter alia to consider and approve The standalone unaudited financial results for the quarter ended on 30th September 2021 along with Limited Review Reports.